Amyloid beta (1-42 specific) Mouse Monoclonal Antibody [Clone ID: 8G7]
CAT#: AM00003BT-N
Amyloid beta (1-42 specific) mouse monoclonal antibody, clone 8G7, Biotin
Conjugation: Unconjugated FITC
Need it in bulk or conjugated? 
                            Get a free quote
                        
CNY 5973.00
| Cited in 1 publication. | 
Specifications
| Product Data | |
| Clone Name | 8G7 | 
| Applications | ELISA, IF, WB | 
| Recommend Dilution | Western blot: 1 μg/ml for HRPO/ECL detection. Recommended blocking buffer: Casein/Tween 20 based blocking and blot incubation buffer. ELISA: 0.05 μg/ml. Immunocytochemistry: 1-10 μg/ml.  | 
        
| Reactivity | Human | 
| Host | Mouse | 
| Clonality | Monoclonal | 
| Immunogen | C-terminal peptide conjugated to KLH | 
| Specificity | This antibody specifically interacts with the C-Terminus of beta-Amyloid (1-42) and does not crossreact with beta-Amyloid (1-40). | 
| Isotype | IgG1 | 
| Formulation | PBS containing 0.09% Sodium Azide as preservative Label: Biotin State: Liquid purified IgG fraction  | 
        
| Concentration | lot specific | 
| Purification | Size Exclusion Chromatography | 
| Conjugation | Biotin | 
| Storage Condition | Store the antibody (aliquote in liquid nitrogen) at -80°C. Avoid repeated freezing and thawing. Thaw aliquots at 37°C. Thawed aliquots may be stored at 2-8°C up to 3 months.  | 
        
| Background | The beta-amyloid peptide (beta A4), proteolytically released from the amyloid precursor protein (APP), is the principal component of senile plaques in Alzheimer's disease. Cleavage of APP by alpha-secretase or alternatively by beta-secretase leads to generation and extracellular release of soluble APP peptides, S-APP-alpha and S-APP-beta, respectively, and the retention of corresponding membrane-anchored C-terminal fragments, C83 and C99. Subsequent processing of C83 by gamma-secretase yields P3 peptides. This is the major secretory pathway and is nonamyloidogenic. Alternatively, presenilin/nicastrin-mediated gamma-secretase processing of C99 releases the amyloid beta proteins, amyloid-beta 40 (Abeta40) and amyloid-beta 42 (Abeta42), major components of amyloid plaques, and the cytotoxic C-terminal fragments, gamma-CTF(50), gamma-CTF(57) and gamma-CTF(59). | 
| Reference Data | |
Citations (1)
| The use of this Antibodies has been cited in the following citations: | 
|---|
| 
                                                Calcium-Sensing Receptor Antagonist NPS 2143 Restores Amyloid Precursor Protein Physiological Non-Amyloidogenic Processing in Aβ-Exposed Adult Human Astrocytes
                                                ,null,
                                                Scientific Reports
                                                ,PubMed ID 28455519
                                                
                                                 | 
                                        
Documents
| Product Manuals | 
| FAQs | 
| SDS | 
Resources
| 抗体相关资料 | 
